Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association

The most recent articles from: Saudi J Gastroenterol November 2014

Saudi J Gastroenterol · Nov 2014

Randomized Controlled Trial Multicenter Study

Efficacy and safety of drotaverine hydrochloride in irritable bowel syndrome: a randomized double-blind placebo-controlled study.

To study the efficacy and safety of drotaverine hydrochloride (HCl) 80 mg tablet given thrice a day in the symptomatic relief of patients with irritable bowel syndrome (IBS). ⋯ A 4-week treatment with drotaverine significantly improves abdominal symptoms in patients with IBS.

read on… or not…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.